The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nanoparticle entrapped docetaxel (CPC634) enhances intratumoral docetaxel exposure compared to conventional docetaxel (Cd) in patients with solid tumors.
 
Florence Atrafi
Travel, Accommodations, Expenses - Abbvie; Astellas Pharma
 
Ruben A.G. van Eerden
No Relationships to Disclose
 
Marte A.M. van Hylckama Vlieg
No Relationships to Disclose
 
Esther Oomen De Hoop
No Relationships to Disclose
 
Peter de Bruijn
No Relationships to Disclose
 
Cristianne J.F. Rijcken
Employment - Cristal Therapeutics
Leadership - Cristal Therapeutics
Stock and Other Ownership Interests - Cristal Therapeutics
 
Rob Hanssen
Employment - Cristal Therapeutics
Honoraria - Cristal Therapeutics
 
Ferry Eskens
Consulting or Advisory Role - Eisai; Ipsen; Merck Serono; Roche
Travel, Accommodations, Expenses - Pfizer
 
Ron H.J. Mathijssen
Research Funding - Astellas Pharma (Inst); Bayer Holding (Inst); Boehringer Ingelheim (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Stijn L.W. Koolen
No Relationships to Disclose